PROVECTUS BIOPHARMACEUTICALS, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Knoxville, TN
SEC filing record 1 source field available
Fiscal year end
31 December
PROVECTUS BIOPHARMACEUTICALS, INC. has filed 1,073 SEC EDGAR filings since 31 Mar 2000

SEC filing history

Showing 101-125 of 264 matching filings.

Per page
25
Current page
5
8-K File 001-36457

FORM 8-K

Filing date
18 Jul 2016
Reporting date
18 Jul 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

FORM 8-K

Filing date
14 Jul 2016
Reporting date
14 Jul 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

8-K

Filing date
14 Jul 2016
Reporting date
14 Jul 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

FORM 8-K

Filing date
13 Jul 2016
Reporting date
13 Jul 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

FORM 8-K

Filing date
12 Jul 2016
Reporting date
12 Jul 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

FORM 8-K

Filing date
11 Jul 2016
Reporting date
11 Jul 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

FORM 8-K

Filing date
28 Jun 2016
Reporting date
28 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

FORM 8-K

Filing date
17 Jun 2016
Reporting date
16 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

FORM 8-K

Filing date
29 Apr 2016
Reporting date
26 Apr 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

FORM 8-K

Filing date
22 Apr 2016
Reporting date
18 Apr 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .